The largest database of trusted experimental protocols

3 protocols using p mkk3 mkk6

1

Western Blot Analysis of Ischemia-Reperfusion Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
After ischemia-reperfusion injury, the cultured cells, or sliced brain tissue from infracted hemisphere, were dissected and homogenized in lysis buffer. The protein extracts were separated on SDS-polyacrylamide gel and electroblotted onto polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA). Membranes were incubated overnight at 4℃ in a buffer with 0.1% Tween with primary antibodies specific to GLP-1 (Abcam, Cambridge, MA, USA), GLP-1R (Abcam), IB-1 (BD Transduction Laboratories, San Diego, CA, USA), phospho-SAPK/JNK (Cell Signaling Technology, Beverly, MA, USA), SAPK/JNK (Cell Signaling Technology), phospho-c-Jun (Cell Signaling Technology), p-MKK3/MKK6 (Cell Signaling Technology), phospho-p38 MAPK (Cell Signaling Technology), p38 (Cell Signaling Technology), p44/42 MAPK (Cell Signaling Technology), MMP-9 (Millipore), COX-2 (Cayman, Ann Arbor, MI, USA), β-actin (Sigma-Aldrich), and Transcription factor IID (TFIID) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Following this, membranes were then incubated with appropriate secondary antibodies. The signal was then detected using a chemiluminescent kit (Thermo Scientific, Rockford, IL, USA). Signals were normalized with β-actin or TFIID to standardize equal protein loading.
+ Open protocol
+ Expand
2

Molecular Mechanisms of RBM3 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNP and diethylamine (DEA) NONOate were purchased from Sigma Aldrich (MO, USA). The RBM3 antibody (ab134946) was from Abcam (Cambridge, MA, USA), and antibodies against, AMPKα (#5832), p-AMPKα (#2535), AKT (#9272), p-AKT (#4060), p-ERK1/2 (#4370), p38 (#9212), p-p38 (#4511), p-JNK1/2 (#4668), p-MKK3/MKK6 (#12280), cleaved PARP (#9541), and β-actin (#4970) were form Cell Signaling Technology (Beverly, MA, USA). Antibodies against ERK1 (sc-93), and JNK1 (sc-474) were from Santa Cruz Biotechnology (CA, USA). The 4,6-diamidino-2-phenylindole dihydrochloride (DAPI) was purchased from Sangon (Shanghai, China). Annexin V-FITC cell apoptosis kit was from Beyotime (Jiangsu, China). Inhibitors SB203580 (p38 MAPK) and SP600125 (JNK), were from Sigma Aldrich. Inhibitors LY294002 (AKT) and U0126 (MEK) were from Cell Signaling Technology. The siRNAs specific to human Rbm3, human miR-143 mimics and antisense inhibitor, and their negative control oligonucleotides were purchased from GenePharma (Shanghai, China).
+ Open protocol
+ Expand
3

Molecular Signaling Analysis in Nrf2 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies against Nrf2, NQO1, β-actin, and Lamin B were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); HO-1, phospho (p)-ERK1/2, p-JNK, p-p38, p-Akt, p-MAPK/ERK kinase (MEK)1/2, p-MKK3/MKK6, p-B-Raf, mixed lineage protein kinase (MLK)3, stress-activated protein kinase/ERK kinase-1 (SEK1)/MKK4, p-MKK7, phospho-apoptosis signal-regulating kinase (p-ASK)1, and phospho-transforming growth factor β-activated kinase (p-TAK1) antibodies were purchased from Cell Signaling Technology (Boston, MA, USA). Peroxidase-conjugated secondary anti-rabbit and anti-goat antibodies were purchased from Santa Cruz Biotechnology, and Alexa-Fluor-555-conjugated secondary antibody was from Cell Signaling Technology (Boston, MA, USA). Specific inhibitors including U0126 (MEK1/2 inhibitor), SP600126 (JNK inhibitor), SB202190 (p38 MAPK inhibitor), and LY294002 (PI3 kinase inhibitor) were obtained from Cell Signaling Technology. Triton X-100, polyethylene glycol and other chemicals were from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!